TrialFrontiers in immunology2023

Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.

Alphonse Ouédraogo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.